OTC Drug RWA Platform Unveiled by Hua Jian, Renhe
The post OTC Drug RWA Platform Unveiled by Hua Jian, Renhe appeared on BitcoinEthereumNews.com.
Hua Jian and Renhe launch the first global RWA platform for OTC drug transactions The system tokenizes OTC assets to improve security and supply chain efficiency Partnership leverages blockchain to modernize drug trading and expand China’s OTC market Concord Medical (HKEX: 0370) has disclosed that its affiliate Hua Jian Medical is partnering with Renhe International, a wholly-owned arm of Renhe Pharmaceutical, to build a new real-world asset (RWA) platform for over-the-counter (OTC) drugs. The venture is being described as the first vertical RWA system dedicated to OTC pharmaceuticals, with the aim of streamlining supply chains and improving transparency in China’s rapidly growing OTC market. Tokenizing OTC Drugs for Secure, Real-Time Trading The project is still in development, but the companies said it will tokenize OTC pharmaceutical assets, enabling secure, traceable, and real-time transactions between manufacturers, distributors, and retailers. By moving drug inventories and transactions onto blockchain rails, the partners expect to cut inefficiencies, lower costs, and improve compliance with regulatory standards, while giving market participants more confidence in product authenticity. Related: RWA Sector Hits Record $25B Value, Led by Private Credit and U.S. Treasuries Renhe’s Role in Tech Infrastructure Renhe International brings its background in digital transformation and blockchain adoption to the initiative. Its role is focused on developing a scalable and secure technology infrastructure to support the platform. Executives noted that the effort reflects Hua Jian’s broader strategy to combine healthcare and technology, particularly in the distribution layer where bottlenecks and fraud risks often arise. Why China’s OTC Market Matters China’s OTC market has been expanding in both urban and rural areas as self-care and preventive medicine gain traction. Industry data cited by the companies suggests this segment of healthcare could become a major growth driver in the coming years. By digitizing and tokenizing OTC drug flows, Hua Jian…
Filed under: News - @ September 16, 2025 10:36 pm